n-3 PUFA for Vascular Cognitive Aging

NCT01953705 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

102

Enrollment

OTHER

Sponsor class

Conditions

Age Related Cognitive Decline
Alzheimer's Disease
Vascular Dementia
Endothelial Dysfunction
Executive Dysfunction

Interventions

DRUG: Omega 3 PUFA
DRUG: Placebo

Sponsor

Oregon Health and Science University

Collaborators

[object Object]